Axsome Therapeutics Inc. (NASDAQ: AXSM) is -19.71% lower on its value in year-to-date trading and has touched a low of $20.63 and a high of $82.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AXSM stock was last observed hovering at around $63.37 in the last trading session, with the day’s loss setting it -1.44% off its average median price target of $96.50 for the next 12 months. It is also 70.51% off the consensus price target high of $210.00 offered by 16 analysts, but current levels are -19.1% lower than the price target low of $52.00 for the same period.
Currently trading at $61.93, the stock is -2.77% and -7.27% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.52 million and changing -2.27% at the moment leaves the stock 13.99% off its SMA200. AXSM registered 116.54% gain for a year compared to 6-month gain of 1.61%.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
The stock witnessed a -0.40% loss in the last 1 month and extending the period to 3 months gives it a -21.97%, and is -2.56% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.61% over the week and 6.01% over the month.
Axsome Therapeutics Inc. (AXSM) has around 383 employees, a market worth around $2.86B and $50.00M in sales. Distance from 52-week low is 200.19% and -24.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-88.20%).
Axsome Therapeutics Inc. (AXSM) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Axsome Therapeutics Inc. (AXSM) is a “Buy”. 16 analysts offering their recommendations for the stock have an average rating of 1.90, where 2 rate it as a Hold and 0 think it is a “Overweight”. 13 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Axsome Therapeutics Inc. is expected to release its quarterly report on 05/10/2023.The EPS is expected to shrink by -32.80% this year
Axsome Therapeutics Inc. (AXSM) Top Institutional Holders
The shares outstanding are 43.48M, and float is at 35.41M with Short Float at 23.72%.
Axsome Therapeutics Inc. (AXSM) Insider Activity
A total of 1 insider transactions have happened at Axsome Therapeutics Inc. (AXSM) in the last six months, with sales accounting for 0 and purchases happening 1 times.
Axsome Therapeutics Inc. (AXSM): Who are the competitors?
The company’s main competitors (and peers) include Pieris Pharmaceuticals Inc. (PIRS) that is trading -49.66% down over the past 12 months.